Employees Retirement System of Texas Invests $4.61 Million in Lam Research Corporation $LRCX

Employees Retirement System of Texas bought a new stake in Lam Research Corporation (NASDAQ:LRCX) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 47,384 shares of the semiconductor company’s stock, valued at approximately $4,612,000.

Several other hedge funds have also added to or reduced their stakes in the company. Brighton Jones LLC increased its position in Lam Research by 1,032.4% during the 4th quarter. Brighton Jones LLC now owns 14,189 shares of the semiconductor company’s stock worth $1,025,000 after buying an additional 12,936 shares during the period. Mutual of America Capital Management LLC acquired a new position in shares of Lam Research in the first quarter valued at about $13,345,000. LPL Financial LLC increased its position in Lam Research by 4.6% during the first quarter. LPL Financial LLC now owns 1,155,707 shares of the semiconductor company’s stock worth $84,020,000 after acquiring an additional 51,280 shares during the period. Federated Hermes Inc. increased its position in Lam Research by 11.8% during the first quarter. Federated Hermes Inc. now owns 590,850 shares of the semiconductor company’s stock worth $42,955,000 after acquiring an additional 62,330 shares during the period. Finally, XTX Topco Ltd raised its stake in Lam Research by 26.0% in the 1st quarter. XTX Topco Ltd now owns 15,078 shares of the semiconductor company’s stock worth $1,096,000 after purchasing an additional 3,116 shares in the last quarter. 84.61% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Lam Research

In related news, insider Ava Harter sold 9,010 shares of the stock in a transaction that occurred on Monday, October 27th. The shares were sold at an average price of $157.47, for a total value of $1,418,804.70. Following the completion of the transaction, the insider owned 56,786 shares of the company’s stock, valued at $8,942,091.42. This represents a 13.69% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Bethany Mayer sold 1,298 shares of the firm’s stock in a transaction that occurred on Monday, November 3rd. The shares were sold at an average price of $159.99, for a total transaction of $207,667.02. Following the completion of the sale, the director owned 1,652 shares in the company, valued at $264,303.48. This represents a 44.00% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 102,608 shares of company stock valued at $14,916,496 in the last quarter. 0.31% of the stock is owned by company insiders.

Lam Research Trading Up 2.1%

Shares of LRCX opened at $155.14 on Thursday. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.60 and a current ratio of 2.21. Lam Research Corporation has a 52-week low of $56.32 and a 52-week high of $167.15. The firm has a market cap of $194.86 billion, a price-to-earnings ratio of 34.17, a PEG ratio of 1.68 and a beta of 1.87. The business’s fifty day moving average is $146.09 and its 200-day moving average is $113.79.

Lam Research (NASDAQ:LRCX) last released its quarterly earnings data on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share for the quarter, beating the consensus estimate of $1.22 by $0.04. Lam Research had a return on equity of 60.60% and a net margin of 29.66%.The business had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.23 billion. During the same period last year, the firm posted $0.86 earnings per share. Lam Research’s revenue was up 27.7% compared to the same quarter last year. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. Equities analysts anticipate that Lam Research Corporation will post 3.71 EPS for the current fiscal year.

Lam Research Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, January 7th. Investors of record on Wednesday, December 3rd will be issued a dividend of $0.26 per share. The ex-dividend date of this dividend is Wednesday, December 3rd. This represents a $1.04 annualized dividend and a dividend yield of 0.7%. Lam Research’s payout ratio is 22.91%.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on the stock. Rothschild & Co Redburn raised their target price on shares of Lam Research from $140.00 to $150.00 and gave the stock a “buy” rating in a report on Tuesday, October 14th. Mizuho increased their price target on Lam Research from $162.00 to $170.00 and gave the stock an “outperform” rating in a research report on Thursday, October 23rd. Deutsche Bank Aktiengesellschaft raised their price objective on Lam Research from $150.00 to $160.00 and gave the stock a “buy” rating in a research note on Thursday, October 23rd. Berenberg Bank upped their target price on Lam Research from $122.00 to $165.00 and gave the company a “buy” rating in a research report on Thursday, October 23rd. Finally, The Goldman Sachs Group raised their price target on Lam Research from $115.00 to $160.00 and gave the stock a “buy” rating in a research report on Wednesday, October 8th. Twenty-six investment analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $152.17.

About Lam Research

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.